According to inhaler monitor company Adherium, the FDA has cleared the Hailie Smartinhaler sensor for use with the Airsupra albuterol / budesonide MDI and with the Breztri Aerosphere budesonide / glycopyrronium / formoterol fumarate MDI, both from AstraZeneca. The Hailie system is already approved for use with a number of different inhalers, including GSK’s Ventolin, Advair, and Flovent MDIs and Ellipta DPIs.
Adherium CEO Paul Mastoridis commented, “Our mission at Adherium has always been to revolutionise the way respiratory conditions are managed. By securing FDA clearance for our Smartinhaler with Airsupra and Breztri, we’re bringing that vision to life, offering patients and healthcare providers a powerful tool in the fight against chronic respiratory diseases. This is just the beginning of our journey to transform respiratory care.”
Read the Adherium press release.
